HomeADCT • NYSE
ADC Therapeutics SA
add
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 16.91M | 0.71% |
Operating expense | -60.81M | 11.07% |
Net income | -30.73M | 63.86% |
Net profit margin | -181.71 | 64.12% |
Earnings per share | — | — |
EBITDA | -32.10M | 19.04% |
Effective tax rate | 1.03% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 250.87M | -9.95% |
Total assets | 321.98M | -9.25% |
Total liabilities | 524.62M | 4.29% |
Total equity | -202.64M | — |
Shares outstanding | 99.08M | — |
Price to book | -0.60 | — |
Return on assets | -24.17% | — |
Return on capital | -31.02% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -30.73M | 63.86% |
Cash from operations | -21.85M | 30.92% |
Cash from investing | -90.00K | 72.48% |
Cash from financing | -1.12M | -111,900.00% |
Net change in cash | -23.41M | 26.42% |
Free cash flow | -2.47M | 78.28% |
Previous close
$1.22
Year range
$1.05 - $5.17
Market cap
119.89M USD
Avg Volume
385.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
About
Founded
2011
Website
Employees
264
